Pediatr. praxi. 2025;26(3):166-170 | DOI: 10.36290/ped.2025.032

Staphylococcus aureus as a pathogen in neonatal infections

MUDr. Veronika Pokorná1, 2, MUDr. Lenka Ryšková, Ph.D.2, 3, MUDr. Tomáš Matějek, Ph.D.1, 2
1 Dětská klinika, Fakultní nemocnice Hradec Králové
2 Lékařská fakulta Univerzity Karlovy v Hradci Králové
3 Ústav klinické mikrobiologie, Fakultní nemocnice Hradec Králové

Staphylococcus aureus (S. aureus) is a significant pathogen responsible for both community-acquired and nosocomial infections in neonates. It contributes to a high incidence of invasive infections, especially in intensive care units. Colonization of the skin and mucous membranes by this agent is a major risk factor, increasing the likelihood of developing an infection up to sixfold. The pathogen causes a wide range of diseases, from localized skin infections to severe systemic conditions (e.g., sepsis, osteomyelitis, meningitis). The clinical presentation depends on the specific type of infection, and in systemic cases, it may initially be nonspecific with rapid progression to a life-threatening state. Diagnosis is based on a combination of clinical symptoms and complementary examinations. The etiological agent is identified through microbiological testing, where blood culture collection usually plays a key role. Treatment is complex and includes causal antimicrobial therapy, supportive care, and targeted management of potential complications. Despite advances in care, S. aureus remains a common nosocomial agent with the potential to cause serious consequences. The prognosis is mainly influenced by the severity of the infection and the presence of complications. A key preventive strategy is minimizing invasive procedures and promptly removing foreign materials.

Keywords: Staphylococcus aureus, neonatal infection, nosocomial infection, multifocal osteomyelitis, fosfomycin.

Accepted: June 16, 2025; Published: July 4, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pokorná V, Ryšková L, Matějek T. Staphylococcus aureus as a pathogen in neonatal infections. Pediatr. praxi. 2025;26(3):166-170. doi: 10.36290/ped.2025.032.
Download citation
PDF will be unlocked 4.7.2026

References

  1. . Ericson JE, Popoola VO, Smith PB, et al. Burden of Invasive Staphylococcus aureus Infections in Hospitalized Infants. JAMA Pediatr. 2015;169(12):1105-1111. Go to original source... Go to PubMed...
  2. . Achermann Y, Seidl K, Kuster SP, et al. Epidemiology of Methicillin-Susceptible Staphylococcus aureus in a Neonatology Ward. Infect Control Hosp Epidemiol. 2015;36(11):1305-1312. Go to original source... Go to PubMed...
  3. . Aneja A, Johnson J, Prochaska EC, et al. Microbiome dysbiosis: a modifiable state and target to prevent Staphylococcus aureus infections and other diseases in neonates. J Perinatol. 2024;44(1):125-130. Go to original source... Go to PubMed...
  4. . Nurjadi D, Eichel VM, Tabatabai P, et al. Surveillance for Colonization, Transmission, and Infection With Methicillin-Susceptible Staphylococcus aureus in a Neonatal Intensive Care Unit. JAMA Netw Open. 2021;4(9):e2124938. Go to original source... Go to PubMed...
  5. . Janota J, Straňák Z. Neonatologie. Medicína ed. Praha: EEZY; 2023.
  6. . Flannery DD, Edwards EM, Coggins SA, et al. Late-Onset Sepsis Among Very Preterm Infants. Pediatrics. 2022;150(6). Go to original source... Go to PubMed...
  7. . Erdenetuya B, Choryok K, Young J, et al. Epidemiology of Catheter-related Bloodstream Infections in Neonatal Intensive Care Units: A Rapid Systematic Literature Review. Korean Journal of Healthcare-Associated Infection Control and Prevention. 2023;28:113-125. Go to original source...
  8. . Urrea Ayala M, Almendral A, Jordan García I, et al. Central line-associated bloodstream infections (CLABSI) in pediatric and neonatal intensive care units-The VINCat program 2013-2022. Enferm Infecc Microbiol Clin (Engl Ed). 2025. Go to original source...
  9. . Kaplan SL, Edwards MS. Skin and soft tissue infections in neonates: Evaluation and management. Wolters Kluwer Health, Inc. 2023 [cited 2025 Feb 23]. Available from: https://www.uptodate.com.
  10. . Zapletalova B, Matejek T, et al. Osteomyelitida u novorozence. Pediatr. praxi. 2023;24(4):257-260. Go to original source...
  11. . Miller JM, Binnicker MJ, Campbell S, et al. Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2024. Go to original source...
  12. . Pediatric and Neonatal Lexi-Drugs [Internet]. Wolters Kluwer Health, Inc. 2025 [cited 2025 Mar 31]. Available from: https://www.uptodate.com.
  13. . Schwab F, Geffers C, Bärwolff S, et al. Reducing neonatal nosocomial bloodstream infections through participation in a national surveillance system. J Hosp Infect. 2007;65(4):319-325. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.